Retatrutide, a novel dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) binding site , is exhibiting promising data in initial clinical studies. Current https://linkingbookmark.com/story21261415/retatrutide-emerging-studies-and-possible-therapeutic-uses